Diagnosis and Management of Autoimmune Dementia
- 27 February 2019
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 21 (3) , 11
Abstract
To describe the clinical, laboratory, and MRI features that characterize cognitive decline in the setting of central nervous system (CNS) autoimmunity, and provide an overview of current treatment modalities.Keywords
This publication has 111 references indexed in Scilit:
- An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based AssaysPLOS ONE, 2013
- The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis ProjectClinical Infectious Diseases, 2012
- Summary of cerebrospinal fluid routine parameters in neurodegenerative diseasesJournal of Neurology, 2010
- Autoimmune Dementia: Clinical Course and Predictors of Immunotherapy ResponseMayo Clinic Proceedings, 2010
- Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenThe Lancet Neurology, 2010
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationAnnals of Neurology, 2009
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodiesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Voltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob DiseaseArchives of Neurology, 2008
- Anti-NMDA receptor encephalitis in JapanNeurology, 2008